Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Deresuscitation Strategy Driven by Tissue Perfusion in Renal Replacement Therapy in Patients With Acute Renal Failure in Intensive Care Unit. A Randomized Study

NCT05817539 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT05817539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05817539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Deresuscitation Strategy Driven by Tissue Perfusion in Renal Replacement Therapy in Patients With Acute Renal Failure in Intensive Care Unit. A Randomized Study
Lead sponsor
Hospices Civils de Lyon
Phase
Not applicable
Overall status
Recruiting
Start date
December 15, 2023
Completion date
January 15, 2028
Enrollment
250 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, fluid overload